Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Laura Sanz Mariano Provencio Luis Alvarez-Vallina Clara Salas Esther Martínez-Martínez Irene Guijarro-Muñoz |
| Publication date | April 12, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |